Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-795-6 | CAS number: 73-22-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Developmental toxicity / teratogenicity
Administrative data
- Endpoint:
- developmental toxicity
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1991
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Acceptable, well documented publication/study report which meets basic scientific principles
Data source
Reference
- Reference Type:
- publication
- Title:
- Impact of supplemental lysine or tryptophan on pregnancy course and outcome in rats
- Author:
- Funk DN, Worthington-Roberts B & Fantel A
- Year:
- 1 991
- Bibliographic source:
- Nutr Res 11, 501-512
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 414 (Prenatal Developmental Toxicity Study)
- GLP compliance:
- no
Test material
- Reference substance name:
- L-tryptophan
- EC Number:
- 200-795-6
- EC Name:
- L-tryptophan
- Cas Number:
- 73-22-3
- Molecular formula:
- C11H12N2O2
- IUPAC Name:
- L-tryptophan
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Details on test animals or test system and environmental conditions:
- Source: Tyler Laboratories, Inc., Bellevue
Age at study initiation: no data
Housing: housed individually in screen bottom cages in a university-approved vivarium
Diet: ad libitum
Water: ad libitum
Acclimation period: no data
ENVIRONMENTAL CONDITIONS
Temperature (°C): 20
Humidity (%): no data
Air changes (per hr): no data
Photoperiod (hrs dark / hrs light): 12 / 12
Administration / exposure
- Route of administration:
- oral: feed
- Vehicle:
- unchanged (no vehicle)
- Details on exposure:
- Rats of the control group or the pair-fed control group were fed with modified American Institute of Nutrition AIN-76 semi-purified diet. To minimize variations, the diet was mixed in large batches and sifted several times. After addition of oik, a part of the diet was separated as basis diet (control diet). The other part was mixed with L-tryptophan. The diets were stored in plastic bags, labeled and frozen until use.
- Analytical verification of doses or concentrations:
- no
- Details on mating procedure:
- animals were time-mated by the breeder
- Duration of treatment / exposure:
- 20 days
- Frequency of treatment:
- continuously via diet
- Duration of test:
- termination on day 20 of gestation
- No. of animals per sex per dose:
- 7
- Details on study design:
- Pilot projects
Two pilot studies were performed to determined if diets with excess of tryptophan support growth and health in non-pregnan female rats. 5 non-pregnant animals each received experimental diet with different tryptophan concentrations (500, 1000, 5000, 10000%). The body weight, behaviour and general apperance were determined for 4 wekks, before the animals were sacrificed and analyzed for alteration in organs or fat deposits. The group receiving 10000% of tryptophan had to be sacrificed after 10 days because of weight loss and changes in general apperance.
A second pilot project was designed to determine if the chosen supplementation level of tryptophan would support pregnant rats so that delivery of viable offspring would be possible. Virgin Sprague Dawley rats were time mated by the supplier.
With the appearance of a seminal plug, the following morning was designated as the beginning of day 0. The animals were delivered to the university vivarium on day 0, weighed and randomly assigned to groups. Six animals were fed the standard control diet and groups of two rats each were fed excess tryptophan (500 or 1000%). Animals were fed ad libitum and food intake and spillage were monitored five times weekly from day 0 through day 20 of gestation. Body weight was measured three times weekly. General appearance of the animals was carefully noted throughout the course of pregnancy. On day 20, the animals were sacrificed, the uteri and ovaries were removed and the numbers of corpora lutea and foetuses plus resorption sites were compared to verify the number of resorptions. Placentas were weighed on a top loading balance after removal of membranes and a general examination for external malformations was completed. The foetuses were measured and sexed.
Main study
Virgin Sprague-Dawley rats were time mated at night by the supplier. Because it was determined in earlier phases of the study that in some cases the experimental diet was associated with reduced food intake, pair-fed control groups were necessary for this final phase of the investigation. Controls (n=11) were fed the control diet ad libitum, while 7 rats each received excess tryptophan (500, 1000 or 2500%). In addition, 7 seven pair-fed control animals were fed the control diet, but at the level recorded for the experimental animals that they were paired with. Food intake was monitored daily from day 0 until day 20 of gestation.
On day 20 of pregnancy, the necropsy procedure referred to above was completed. Approximately three-fourths of the foetuses from each litter were placed in Bouin’s solution for subsequent examination of any structural variations. The remaining one-fourth of the foetuses from each litter was placed in 95% ethanol for later processing with alizarin stain which facilitated skeletal examination. After two weeks’ fixation in Bouin’s solution, the foetuses were razor sectioned. The head, neck and lower trunk were serially sectioned with a razor blade and after opening the thoracic cavity; sagittal sections were made of the heart. The foetuses stained for approximately 24 hr with alizarin red stain and subsequently placed in increasing concentrations of glycerine were examined generally for skeletal defects and variations in ossification. The number of ribs and phalanges were counted.
Examinations
- Maternal examinations:
- CAGE SIDE OBSERVATIONS: No data
DETAILED CLINICAL OBSERVATIONS: No data
BODY WEIGHT: Yes
FOOD CONSUMPTION AND COMPOUND INTAKE: Yes
POST-MORTEM EXAMINATIONS: No data - Ovaries and uterine content:
- Ovaries and uterine content: Yes
Examinations included number of corpora lutea, number of implantations and number of early / late resorptions - Fetal examinations:
- External examinations: No data
Soft tissue and skeletal examinations: Yes (3/4 and 1/4 per litter, respectively) - Statistics:
- One-way analysis of variance (ANOVA) and Duncan’s multiple comparison procedure
Results and discussion
Results: maternal animals
Maternal developmental toxicity
- Details on maternal toxic effects:
- Maternal toxic effects:yes. Remark: significantly lower mean maternal weight gain
Details on maternal toxic effects:
MORTALITY
There were no substance-related or spontaneous mortalities in any of the groups.
Pilot projects
The first pilot project provided data related to the effects of amino acid supplementation on growth and behaviour of adult female rats. Excess tryptophan (10000%) promoted rapid weight loss and was therefore deemed unacceptable for further study. The animals fed the higher amino acid supplemented diets were more active when compared to the control animals or those on the lower supplemented diets. Otherwise, all of these animals appeared reasonably healthy with the exception of those provided excess tryptophan (5000%), which developed scaly tails and thinning hair. Based on these observations, 500 and 1000% excess tryptophan were chosen for further investigation.
The second pilot project examined the impact of the selected diets on the course of pregnancy. All animals appeared healthy and gained weight steadily throughout the course of pregnancy. Necropsy revealed viable foetuses and in total 13 visible resorptions were present among all experimental animals and 1 visible resorption among the 6 control animals. The placentas of all groups appeared normal. These results supported the use of the chosen diets for the next step in the study with an additional level of tryptophan supplementation (2500%).
Main study
The tryptophan groups and their pair-fed controls consumed decreasing amounts of diet with increasing levels of tryptophan. Rats fed the highest tryptophan-supplemented diet (2500%) had a significantly lower mean maternal weight gain than any of the other groups and also a significantly smaller food efficiency ratio.
Effect levels (maternal animals)
- Dose descriptor:
- NOAEL
- Effect level:
- ca. 2 220 mg/kg bw/day
- Basis for effect level:
- other: maternal toxicity
Results (fetuses)
- Details on embryotoxic / teratogenic effects:
- Embryotoxic / teratogenic effects:yes
Details on embryotoxic / teratogenic effects:
There were no statistically significant differences within tryptophan groups in the mean number of viable foetuses. There were no significant differences in the mean number of early resorptions. Rats dosed with 1000% had significantly more late resorptions than any of the other tryptophan dosed rats. Total foetal weights per litter differed significantly between the highest and lowest tryptophan-supplemented groups (2500%: 32.4 +/- 4.3 g; 500%: 47.3 +/- 2.1 g). Within the tryptophan groups, two groups differed significantly from each other in average foetal weight (2500%: 3.7 +/- 0.1 g vs. 4.1 +/- 0.1 g in 1000% pair-fed controls). Considerable variation was found among the tryptophan groups in foetal length (not further specified). Among the tryptophan groups, no groups of rats differed significantly from each other in total placental weight. No significant differences were found in the ratio of males to females. No obvious congenital malformations or abnormalities were observed in any of the foetuses. No skeletal variations were found consistently within any group although some variation in ossification of phalanges existed, particularly in the smaller foetuses. Sectioning of foetuses preserved in Bouin’s solution showed that the foetuses were structurally normal, only one foetus in the 1000% group showed a missing left kidney.
Effect levels (fetuses)
open allclose all
- Dose descriptor:
- NOAEL
- Effect level:
- ca. 2 220 mg/kg bw/day
- Basis for effect level:
- other: embryotoxicity
- Dose descriptor:
- NOAEL
- Effect level:
- ca. 5 540 mg/kg bw/day
- Basis for effect level:
- other: teratogenicity
Fetal abnormalities
- Abnormalities:
- not specified
Overall developmental toxicity
- Developmental effects observed:
- not specified
Applicant's summary and conclusion
- Conclusions:
- The results of this study are indicating that variable levels of tryptophan supplementation do not cause grossly recognizable foetal malformations in rats. Highly supplemented tryptophan diets (2500% excess) caused significant decreases in both maternal weight gain and foetal size.
From this study NOAEL values for maternal toxicity and embryotoxicity of ca. 2220 mg/kg bw/d can be derived.
The NOAEL value for teratogenicity is ca. 5540 mg/kg bw/d.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.